Physician profile
Chad Johnston
NPI 1962441212
$10,241.23
in general payments reported to CMS, 2019-2025
31 companies · $1,871 in 2025
The $1,871 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,838 · 2020: $593 · 2021: $379 · 2022: $1,889 · 2023: $1,758 · 2024: $1,912 · 2025: $1,871.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,063 · Education: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,063.13 |
| Education | $478.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,274.50 | 2019-2025 | |
| Genzyme Corporation | $999.18 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $874.61 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $738.11 | 2019-2025 | Tremfya |
| Pfizer INC. | $530.70 | 2019-2025 | |
| Ucb, INC. | $475.03 | 2019-2025 | Bimzelx |
| Incyte Corporation | $472.09 | 2022-2025 | Opzelura |
| Novartis Pharmaceuticals Corporation | $432.07 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $378.37 | 2020-2024 | |
| Sanofi-Aventis U.S. LLC | $271.98 | 2019-2023 | |
| Hill Dermaceuticals, INC. | $255.54 | 2022 | |
| Leo Pharma INC. | $246.86 | 2020-2024 | Adbry |
| Genentech USA, INC. | $232.43 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $209.97 | 2023-2025 | Sotyktu |
| Lilly USA, LLC | $175.64 | 2019-2025 | Taltz, Olumiant, Ebglyss |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $131.00 | 2019-2025 | Nemluvio |
| Amgen INC. | $97.22 | 2019-2023 | Otezla, Enbrel |
| Arcutis Biotherapeutics, INC. | $65.68 | 2023-2025 | Zoryve |
| Dermavant Sciences, INC. | $50.97 | 2023-2024 | Vtama |
| Organogenesis INC. | $47.54 | 2024-2025 | Puraply Wound Matrix |
| Dusa Pharmaceuticals, INC. | $38.87 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.93 | 2020-2025 | Siliq, Cabtreo, Jublia |
| Celgene Corporation | $33.47 | 2019 | |
| Vyne Pharmaceuticals INC. | $28.93 | 2020 | |
| Dermira, INC. | $28.25 | 2019-2020 | |
| Kerecis Limited | $27.56 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.50 | 2023 | Spevigo |
| Biofrontera INC. | $19.98 | 2019 | |
| Almirall LLC | $19.08 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.25 | 2023 | Nuzyra |
| Musculoskeletal Transplant Foundation INC. | $12.92 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.